Shopping Cart
- Remove All
- Your shopping cart is currently empty
NVP-DPP728 dihydrochloride is a highly potent, selective, and orally active inhibitor of dipeptidyl peptidase IV (DPP-IV), with a binding affinity (K i ) of 11 nM. This compound proves useful for investigating diabetes mellitus in research studies.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | Backorder |
Description | NVP-DPP728 dihydrochloride is a highly potent, selective, and orally active inhibitor of dipeptidyl peptidase IV (DPP-IV), with a binding affinity (K i ) of 11 nM. This compound proves useful for investigating diabetes mellitus in research studies. |
Targets&IC50 | DPP4:11 nM (Ki) |
In vitro | NVPDPP728 selectively inhibits DPP-IV in both human and rat plasma, exhibiting high potency with IC50 values between 5-10 nM. Its selectivity exceeds 15,000-fold compared to DPP-II and various proline-cleaving proteases[1]. |
In vivo | NVP-DPP728 (3.72 mg/kg; p.o.) suppresses DPP-IV, likely amplify ng endogenous GLP-1 effects to enhance insulin secretion and glucose tolerance in obese (fa/fa) and lean (FA/?) Zucker rats, as evidenced by inhibited plasma DPP-IV activity. |
Alias | NVP-DPP728 dihydrochloride |
Molecular Weight | 371.27 |
Formula | C15H20Cl2N6O |
Cas No. | 207556-62-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.